Showing 101 - 120 results of 8,704 for search '(( significant decrease prevalence ) OR ( significant ((teer decrease) OR (greater decrease)) ))', query time: 0.53s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

    Published 2025
    “…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”
  6. 106

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    “…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …”
  7. 107

    Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

    Published 2022
    “…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…”
  8. 108
  9. 109

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  10. 110

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  11. 111

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120